维普期刊资源整合服务平台（V6.5）

维普中文期刊产品整合服务

12篇 您的检索式：作者名="Cornali"

选中清除导出查看参考文献查看引证文献引用追踪共1页首页上一页第1页下一页末页 /1 跳转

		题名	作者	年代	出处	被引量
	1	Prevention of Peritoneal Metastases from Colon Cancer in High-Risk Patients: Preliminary Results of Surgery plus Prophylactic HIPEC显示文摘	Paolo Sammartino Simone Sibio Daniele Biacchi Maurizio Cardi Fabio Accarpio Pietro Mingazzini Maria Sofia Rosati Tommaso Cornali Angelo Di Giorgio Paul H. Sugarbaker	2012	Gastroenterology Research and Practice2012，，：	2
	2	Vascular growth factor regulate angiogenesis and vascular permeability in Kaposi' s sarcoma 显示文摘	Cornali E ZietZ C Benelli R	1996	Am J Pathol1996，149，6：	1
	3	Emergent Decompressive Craniectomy in patients with fixed dilated pupils due to cerebral venous and dural sinus thrombosis:report of three cases显示文摘	Stefini R Latronico N Cornali C		0，，03：	1
	4	Probing interactions between fl-glucan and bile salts at atomic de- tail by 1H-13C NMR assays显示文摘	Mikkelsen MS Cornali SB Jensen MG	2014	Journal of Agricultural and Food Chemistry2014，62，11：	1
	5	Vascular endothelial growth factor regulate angiogenesis and vascular permeability in Kaposi's sarcoma显示文摘	Cornali E Zietz C Benelli R	1996	Am J Pathol1996，149，8：	1
	6	Vascular growth factor regulates angiogenesis and vascular permeability in kaposis sarcoma显示文摘	Cornali E Zietz C Benelli R	1996	Am J Pathol1996，149，6：	1
	7	Vascular growth factors regulates angiogenesis and vascular permeability in Kaposi's sarcoma显示文摘	Cornali E Zietz C Benelli R	1996	Am J Pathol1996，149，：	1
	8	The helical domain of GBP-1 mediates the inhibition of endothelial cell proliferation by inflammatory cytokines显示文摘	Guenzi E Topolt K Cornali E	2001	EMBO J2001，20，20：	1
	9	Ruptured aneu- rysm in sphenoid sinus:which is the best treatment显示文摘	Ronchetti G Panciani P P Cornali C et aL	2013	Case Rep Neurol2013，5，1：	1
	10	The helical domain of GBP-1 mediates the inhibition of endothelial cell proliferation by inflammatory cytokines显示文摘	Guenzi E Topolt K Cornali E	2001	Embo J2001，20，20：	1
	11	Long-term results after proactive management for locoregional control in patients with colonic cancer at high risk of peritoneal metastases显示文摘	P. Sammartino S. Sibio D. Biacchi M. Cardi P. Mingazzini M. S. Rosati T. Cornali B. Sollazzo J. Maherfouad Atta A. Giorgio	2014	International Journal of Colorectal Disease2014，，9：	1
	12	Cytoreductive surgery after recurrent epithelial ovarian cancer and at other timepoints显示文摘In this descriptive review we look at the role of surgery for advanced ovarian cancer at other timepoints apart from the initial cytoreduction for front-line therapy or interval cytoreductive surgery after neoadjuvant chemotherapy. The chief surgical problem to face after primary treatment is recurrent ovarian cancer. Of far more marginal concern are the second-look surgical procedures or the palliative efforts intended to resolve the patient's symptoms with no curative intent. The role of surgery in recurrent ovarian cancer remains poorly defi ned. Current data, albeit from non-randomized studies, nevertheless clearly support surgical cytoreduction in selected patients, a rarely curative expedient that invariably yields a marked survival advantage over chemotherapy alone. Despite these fi ndings, some consider it too early to adopt secondary cytoreduction as the standard care for patients with recurrent ovarian cancer and a randomized study is needed. Two ongoing randomized trials(Arbeitsgemeinschaft Gynkologische Onkologie-Desktop Ⅲ and Gynecologic Oncology Group 213) intend to verify the role of secondary cytoreduction for platinum-sensitive ovarian cancer compared with chemotherapy considered as standard care for these patients. We await the results of these two trials for a defi nitive answer to the matter.	Paolo Sammartino Tommaso Cornali Marialuisa Framarino dei Malatesta Pompiliu Piso	2013	World Journal of Obstetrics and Gynecology2013，2，4：	0

返回顶部每页显示：

共1页首页上一页第1页下一页末页 /1 跳转

goolge学术搜索-维普

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1　渝公网安备 50019002500403号　违法和不良信息举报中心

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费